Synapse - Alexander Lesokhin

Results (375)

Evaluating serum free light chain ratio as a biomarker for multiple myeloma

Meeting Abstract

Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
Clinical Lymphoma, Myeloma and Leukemia (2022)

Fulltext@MSK | Save

African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients

Meeting Abstract

Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
Clinical Lymphoma, Myeloma and Leukemia (2022)

Fulltext@MSK | Save

Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: A retrospective study of 34 patients highlighting the need for consensus criteria

Meeting Abstract

Pianko, M. J.; Tiutan, T.; Derkach, A.; Jaffer-Sathick, I.; Rossi, A.; Salvatore, S.; Landau, H.; Lahoud, O.; Korde, N.; Mailankody, S.; more...
Clinical Lymphoma, Myeloma and Leukemia (2022)

Fulltext@MSK | Save

Cevostamab is efficacious and well tolerated in patients aged < 65 and ≥65 years with relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Krishnan, A.; Cohen, A.; Trudel, S.; Spencer, A.; Lesokhin, A.; Wong, C.; Choeurng, V.; Cooper, J.; Sumiyoshi, T.; Goodman, G.; more...
Clinical Lymphoma, Myeloma and Leukemia (2022)

Fulltext@MSK | Save

Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study

Meeting Abstract

Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
Clinical Lymphoma, Myeloma and Leukemia (2022)

Fulltext@MSK | Save

Chemotherapy signatures reveal the evolutionary history of post-melphalan myeloid neoplasm

Meeting Abstract

Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Coffey, D.; Lu, S.; Bolli, N.; Bolton, K.; Park, J.; more...
Clinical Lymphoma, Myeloma and Leukemia (2022)

Fulltext@MSK | Save

Microbial changes in response to a plant-based diet and/or supplements in SMM patients: A national multi-arm randomized prospective telehealth study via HealthTree: The nutrition prevention (NUTRIVENTION-2) study

Meeting Abstract

Castro, F.; Sweeney, N. W.; Derkach, A.; Traore, K.; Anuraj, A.; Guttentag, L.; Blaslov, J.; Sahagun, A.; Hydren, J.; Chmielewski, C.; more...
Blood (2022)

Fulltext@MSK | Save

Low intake of fruits and vegetables and high intake of processed meats and juices are associated with risk of MGUS in the national health and nutrition examination survey (NHANES) database

Meeting Abstract

Joseph, J. M.; Tang, L.; Hillengass, J.; Moysich, K.; Landgren, O.; Usmani, S.; Lesokhin, A. M.; McCann, S. E.; Shah, U. A.
Blood (2022)

Fulltext@MSK | Save

Initial results of dose escalation of ISB 1342, a novel CD3xCD38 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM)